Skip to main content
SpringerLink
Log in

Dapagliflozin/empagliflozin

Diabetic ketoacidosis, euglycaemic diabetic ketoacidosis and weight loss: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nolan BJ, et al. Beware Ketoacidosis with SGLT2 Inhibitors in Latent Autoimmune Diabetes of the Adult. American Journal of Medicine 133: e422-e424, No. 8, Aug 2020. Available from: URL: http://doi.org/10.1016/j.amjmed.2019.12.006

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dapagliflozin/empagliflozin. Reactions Weekly 1823, 139 (2020). https://doi.org/10.1007/s40278-020-83767-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-83767-5

Search

Navigation